What is Pharmaceutical Compounding?
Pharmaceutical compounding is the practice of creating customised medications tailored to an individual patient's specific needs. Unlike mass-manufactured pharmaceuticals, which are produced in standardised doses and formulations, compounded medicines can be prepared in precise dosages, alternative delivery forms (such as sublingual troches, transdermal creams, or injectable solutions), and without certain excipients or allergens that a patient may not tolerate. This flexibility makes compounding an essential component of personalised medicine.
In South Africa, compounding pharmacies operate under the oversight of the South African Pharmacy Council (SAPC) and must comply with Good Pharmacy Practice (GPP) standards. The South African Health Products Regulatory Authority (SAHPRA) provides the regulatory framework for ensuring that compounded medicines meet safety, quality, and efficacy standards comparable to commercially available products.
The Regulatory Landscape
South Africa's regulatory environment for compounded medicines has evolved significantly in recent years. SAHPRA has increased scrutiny of compounding practices to ensure patient safety, while simultaneously recognising the legitimate clinical need for compounded formulations — particularly in areas where commercial products are unavailable, unaffordable, or inappropriate for specific patient populations. The Section 14(4) exemption under the Medicines and Related Substances Act allows pharmacists to compound medicines on prescription, provided they adhere to strict quality controls.
The growing global interest in peptide therapies has placed South African compounding pharmacies at a pivotal juncture. As demand for GLP-1 agonists, regenerative peptides, and NAD+ formulations increases, pharmacies must invest in advanced quality assurance systems, including sterile compounding facilities, potency testing, endotoxin screening, and stability studies. Pharmacies that meet these higher standards will play a critical role in expanding patient access to innovative therapies.
DOSIST's Approach to Quality and Compliance
At DOSIST, all compounded formulations are prepared in accordance with SAHPRA guidelines and SAPC Good Pharmacy Practice standards. Our facility maintains strict environmental controls for sterile compounding, and every batch undergoes potency verification and sterility testing before release. Prescriptions are issued only by registered medical practitioners after clinical assessment, ensuring that compounded peptide therapies are used appropriately, safely, and effectively.
- Compounding enables personalised dosing, formulations, and delivery methods
- SAHPRA and SAPC provide the regulatory framework for quality assurance
- Section 14(4) exemption permits prescription-based compounding
- Sterile compounding standards are essential for injectable peptide therapies
